MedPath

A Study to Evaluate the Effect of KarXT on Urological Safety

Not Applicable
Not yet recruiting
Conditions
Schizophrenia
Interventions
Drug: Xanomeline/trospium chloride
Registration Number
NCT07221877
Lead Sponsor
Bristol-Myers Squibb
Brief Summary

The purpose of this study is to characterize the effect of KarXT on voiding dynamics and urological safety in participants with DSM-5 schizophrenia.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
KarXTXanomeline/trospium chloride-
Primary Outcome Measures
NameTimeMethod
Change from baseline in voiding dynamics (Qmax) over timeUp to 12 months
Change from baseline in post-void residual volume (PVR) over timeUp to 12 months
Secondary Outcome Measures
NameTimeMethod
Number of participants with a change from baseline in urinalysis parameters over timeUp to 12 months
Number of participants with vital sign abnormalitiesUp to 12 months
Number of participants with Adverse Events (AEs)Up to 12 months
Change from baseline in IPSS over timeUp to 12 months
Number of participants with electrocardiogram (ECG) abnormalitiesUp to 12 months
Number of participants with AEs of Special Interest (AESIs)Up to 12 months
Number of participants with Serious AEs (SAEs)Up to 12 months
Number of participants with suicidal ideation or behaviorUp to 12 months

Trial Locations

Locations (16)

Local Institution - 0017

🇺🇸

Little Rock, Arkansas, United States

Local Institution - 0007

🇺🇸

Bellflower, California, United States

Local Institution - 0009

🇺🇸

Culver City, California, United States

Local Institution - 0006

🇺🇸

Los Alamitos, California, United States

Local Institution - 0016

🇺🇸

Orange, California, United States

Local Institution - 0003

🇺🇸

Miami, Florida, United States

Local Institution - 0008

🇺🇸

Miami, Florida, United States

Local Institution - 0004

🇺🇸

Stuart, Florida, United States

Local Institution - 0005

🇺🇸

Chicago, Illinois, United States

Local Institution - 0010

🇺🇸

Chicago, Illinois, United States

Scroll for more (6 remaining)
Local Institution - 0017
🇺🇸Little Rock, Arkansas, United States
Site 0017
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.